Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.57)
# 828
Out of 4,754 analysts
137
Total ratings
51.88%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $311.51 | +20.38% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $9.43 | +27.25% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $58.59 | +45.08% | 17 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Outperform | $610 → $640 | $467.05 | +37.03% | 14 | Dec 6, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $22.53 | +64.23% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $311.28 | +28.50% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $129.87 | +29.36% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $261.54 | +7.06% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $94.99 | +52.65% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $13.06 | +206.28% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.10 | +61.29% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.43 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $591.27 | +9.93% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $92.00 | +57.61% | 10 | Oct 28, 2022 |
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $311.51
Upside: +20.38%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $9.43
Upside: +27.25%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $58.59
Upside: +45.08%
UnitedHealth Group
Dec 6, 2024
Maintains: Outperform
Price Target: $610 → $640
Current: $467.05
Upside: +37.03%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $22.53
Upside: +64.23%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $311.28
Upside: +28.50%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $129.87
Upside: +29.36%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $261.54
Upside: +7.06%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $94.99
Upside: +52.65%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $13.06
Upside: +206.28%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.10
Upside: +61.29%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.43
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $591.27
Upside: +9.93%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $92.00
Upside: +57.61%